K-ras Codon-Specific Mutations Produce Distinctive Metabolic Phenotypes in Human Fibroblasts
暂无分享,去创建一个
Marta Cascante | Gabriel Capellá | Ramon Mangues | Pedro Vizán | M. Cascante | L. Boros | G. Capellá | R. Mangues | A. Figueras | S. Bassilian | W. Lee | P. Vizán | Sara Bassilian | Shu Lim | Laszlo G. Boros | Agnès Figueras | Wai-Nang P. Lee | Shu K Lim | Pedro Vizán
[1] M Cascante,et al. Wheat Germ Extract Decreases Glucose Uptake and RNA Ribose Formation but Increases Fatty Acid Synthesis in MIA Pancreatic Adenocarcinoma Cells , 2001, Pancreas.
[2] S. Finkelstein,et al. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K‐ras‐2 mutation type , 1993, Cancer.
[3] M. Cascante,et al. Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism? , 1998, Medical hypotheses.
[4] A. Pellicer,et al. Neutron radiation can activate K-ras via a point mutation in codon 146 and induces a different spectrum of ras mutations than does gamma radiation , 1990, Molecular and cellular biology.
[5] G. Capellá,et al. Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors. , 1991, Environmental health perspectives.
[6] S. Bassilian,et al. Mass isotopomer study of glutamine oxidation and synthesis in primary culture of astrocytes. , 1996, Developmental neuroscience.
[7] Marta Cascante,et al. Metabolic profiling of cell growth and death in cancer: applications in drug discovery. , 2002, Drug discovery today.
[8] W. Zwerschke,et al. Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7 , 2001, Oncogene.
[9] P. Wals,et al. Studies of glycogen synthesis and the Krebs cycle by mass isotopomer analysis with [U-13C]glucose in rats. , 1989, The Journal of biological chemistry.
[10] G. Capellá,et al. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression. , 2000, Cancer research.
[11] Marta Cascante,et al. Mass isotopomer study of the nonoxidative pathways of the pentose cycle with [1,2-13C2]glucose. , 1998, American journal of physiology. Endocrinology and metabolism.
[12] E. Kandel,et al. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. , 2001, Genes & development.
[13] G. Semenza,et al. Oncogenic alterations of metabolism. , 1999, Trends in biochemical sciences.
[14] G. Capellá,et al. Codon 12 and codon 13 mutations at the K‐ras gene induce different soft tissue sarcoma types in nude mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] S. Finkelstein,et al. Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. , 1993, Archives of surgery.
[16] C. Marshall,et al. Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia , 1985, Nature.
[17] M. Wigler,et al. Analysis of the transforming potential of the human H-ras gene by random mutagenesis. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[18] D. Kell,et al. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations , 2001, Nature Biotechnology.